Eli Lilly Confronts Georgia Clinics Over Experimental Weight-Loss Drug Promotion | Retatrutide News

Eli Lilly is addressing the unauthorized promotion of its experimental weight-loss drug, Retatrutide, by clinics in Georgia. This highlights concerns ab...
Market News · November 4, 2026